Iconovo Investor Relations Material
Latest events
Investor Update
Iconovo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Iconovo
Access all reports
Iconovo AB develops and licenses inhalation devices for inhaled medicine. The company’s product portfolio includes the Icon, a disposable handheld inhaler, which is a solution for respiratory diseases; Clickhaler, a drug delivery inhaler that is used to treat respiratory airways inflammation and asthma; and Easyhaler, a powder inhaler that is used for the treatment of asthma and chronic obstructive pulmonary disease.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ICO
Country
🇸🇪 Sweden